TGM2 and breast cancer: Moreover, miR-205 is inhibited by the transglutaminase 2 (TG2) in order to induce EMT in breast cancer cell lines; the GTP binding activity of TG2 represses miR-205 expression, thus allowing ZEB1 expression and function in in vitro assays [49].